• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会人口因素对低危主动监测患者明确干预的影响。

Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.

机构信息

Section of Urology, Department of Surgery, Medical College of Georgia-Augusta University, Augusta, GA.

Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON.

出版信息

Urology. 2021 Sep;155:117-123. doi: 10.1016/j.urology.2021.01.053. Epub 2021 Feb 10.

DOI:10.1016/j.urology.2021.01.053
PMID:33577898
Abstract

OBJECTIVES

To investigate sociodemographic factors influencing decision of initially active surveillance (AS) prostate cancer (CaP) patients to opt for definitive therapy, and, specifically, choice of radical prostatectomy (RP) versus radiation therapy (XRT).

METHODS

The Surveillance, Epidemiology, and End Results (SEER) Prostate with Watchful Waiting database was used to identify AS patients diagnosed with NCCN low-risk CaP between 2010 and 2015. We sought to determine predictors of treatment type using multivariable logistic regression analyses.

RESULTS

Out of 32,874 men included, 21,255 (64.7%) underwent delayed treatment, with 3,751 (17.6%) and 17,463 (82.2%) opting for RP and XRT, respectively. Patients who were married (Odds Ratio [OR]: 1.18, P <.001), insured (OR 2.94, P <.001), of higher socioeconomic status (OR 1.67 for highest vs lowest, P <.01), and residing in a Southeastern or Midwestern region (ORs 1.26 and 1.22 vs Northeast, respectively, P <.01) were significantly more likely to undergo definitive intervention. A significant interaction between patient race and marital/socioeconomic statuses on the decision-making process was identified. Decision for XRT (vs RP) was more likely in older (OR 11.6 for 70-79 vs 50-59 years, P <.01), unmarried (OR 1.89, P <.01), African American (OR 1.41, P .018), and higher socioeconomic status (OR 1.54 for highest versus lowest quartile, P <.01) patients.

CONCLUSION

The majority of patients initially treated with AS underwent delayed treatment. After accounting for pathologic characteristics, the interaction of sociodemographic factors including race, socioeconomic status, marital status, insurance status, and region of residence are significantly associated with the likelihood of undergoing definitive therapy.

摘要

目的

调查影响初始主动监测(AS)前列腺癌(CaP)患者决定选择确定性治疗的社会人口学因素,特别是选择根治性前列腺切除术(RP)还是放射治疗(XRT)。

方法

使用监测、流行病学和最终结果(SEER)前列腺观望等待数据库,确定 2010 年至 2015 年间被诊断为 NCCN 低危 CaP 的 AS 患者。我们试图通过多变量逻辑回归分析确定治疗类型的预测因素。

结果

在纳入的 32874 名男性中,21255 名(64.7%)接受了延迟治疗,其中 3751 名(17.6%)和 17463 名(82.2%)分别选择了 RP 和 XRT。已婚(优势比 [OR]:1.18,P <.001)、有保险(OR 2.94,P <.001)、社会经济地位较高(OR 1.67 为最高 vs 最低,P <.01)和居住在东南部或中西部地区(OR 分别为 1.26 和 1.22,与东北部相比,P <.01)的患者更有可能接受确定性干预。还发现患者种族和婚姻/社会经济地位对决策过程的显著交互作用。与 RP 相比,选择 XRT(vs RP)的可能性更高,包括年龄较大(OR 11.6 为 70-79 岁 vs 50-59 岁,P <.01)、未婚(OR 1.89,P <.01)、非裔美国人(OR 1.41,P <.018)和较高的社会经济地位(OR 1.54 为最高与最低四分位数,P <.01)。

结论

大多数初始接受 AS 治疗的患者接受了延迟治疗。在考虑到病理特征后,种族、社会经济地位、婚姻状况、保险状况和居住地区等社会人口学因素的相互作用与接受确定性治疗的可能性显著相关。

相似文献

1
Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.社会人口因素对低危主动监测患者明确干预的影响。
Urology. 2021 Sep;155:117-123. doi: 10.1016/j.urology.2021.01.053. Epub 2021 Feb 10.
2
Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).与临床局限性前列腺癌初始治疗和生存相关的因素:来自疾病预防控制中心-国家癌症监测、流行病学和结果数据库(NPCR)模式研究(PoC1)的结果。
BMC Cancer. 2010 Apr 19;10:152. doi: 10.1186/1471-2407-10-152.
3
A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.一项基于人群的对60岁以下局限性前列腺癌年轻男性当代护理模式的分析。
Int Urol Nephrol. 2015 Oct;47(10):1629-34. doi: 10.1007/s11255-015-1096-8. Epub 2015 Sep 2.
4
Population-Based Assessment of Determining Treatments for Prostate Cancer.基于人群的前列腺癌治疗方法评估。
JAMA Oncol. 2015 Apr;1(1):60-7. doi: 10.1001/jamaoncol.2014.192.
5
Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice.对预后良好的中危前列腺癌患者进行主动监测:延迟干预和治疗选择的预测因素。
Can Urol Assoc J. 2022 Jan;16(1):E7-E14. doi: 10.5489/cuaj.7272.
6
Influence of sociodemographic factors on treatment's choice for localized prostate cancer in Portugal.社会人口因素对葡萄牙局限性前列腺癌治疗选择的影响。
Arch Ital Urol Androl. 2020 Apr 6;92(1):45-49. doi: 10.4081/aiua.2020.1.45.
7
Outcomes of clinically localized prostate cancer patients managed with initial monitoring approach versus upfront local treatment: a North American population-based study.北美人群为基础的研究:采用初始监测方法与直接局部治疗处理局限性前列腺癌患者的临床结局。
Clin Transl Oncol. 2019 Dec;21(12):1673-1679. doi: 10.1007/s12094-019-02098-8. Epub 2019 Mar 30.
8
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.局部前列腺癌管理中的时间趋势及种族、保险和社会经济地位的影响。
Eur Urol. 2017 May;71(5):729-737. doi: 10.1016/j.eururo.2016.08.047. Epub 2016 Sep 3.
9
Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.主动监测在中危前列腺癌患者中的应用及早期死亡率结果。
Cancer. 2019 Sep 15;125(18):3164-3171. doi: 10.1002/cncr.32202. Epub 2019 May 31.
10
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis.临床晚期前列腺癌患者确定性治疗的生存获益:基于竞争风险分析的治疗所需人数估计
BJU Int. 2014 Dec;114(6b):E62-E69. doi: 10.1111/bju.12645. Epub 2014 Jul 15.

引用本文的文献

1
Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer.了解低危甲状腺癌和肾癌的非手术治疗的医院层面模式。
JAMA Netw Open. 2022 Nov 1;5(11):e2242210. doi: 10.1001/jamanetworkopen.2022.42210.
2
Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States.美国男性前列腺癌主动监测或密切观察的观察强度。
Prostate Cancer Prostatic Dis. 2023 Jun;26(2):395-402. doi: 10.1038/s41391-022-00580-z. Epub 2022 Jul 26.
3
Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice.
对预后良好的中危前列腺癌患者进行主动监测:延迟干预和治疗选择的预测因素。
Can Urol Assoc J. 2022 Jan;16(1):E7-E14. doi: 10.5489/cuaj.7272.